Flobow Wart Remover

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common warts characterized by a rough, cauliflower-like appearance.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and soaking in warm water for approximately 5 minutes may facilitate this process. After cleansing, the area must be dried completely. A small amount of the medication should then be applied to cover each wart, ensuring that it is allowed to dry. This application should be repeated twice daily as necessary, with treatment continuing for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Application on irritated or infected skin, or on areas exhibiting redness, is not recommended due to the potential for exacerbating the condition.

Patients with diabetes or poor blood circulation should avoid use, as these conditions may increase the risk of adverse effects.

Additionally, the product should not be applied to birthmarks, warts with hair growth, or moles, as these may present unique risks or complications.

Warnings and Precautions

The product is intended for external use only. It is imperative to avoid contact with the eyes. In the event of accidental exposure to the eyes, it is recommended to rinse thoroughly with water for a minimum of 15 minutes. Additionally, users should refrain from inhaling vapors associated with the product.

In cases of ingestion, immediate medical assistance should be sought, or the user should contact a Poison Control Center without delay.

Should any discomfort persist during the use of this product, it is advised to discontinue use and consult a healthcare professional for further evaluation and guidance.

Side Effects

Patients using this product should be aware that it is intended for external use only and must avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is recommended to rinse thoroughly with water for at least 15 minutes. Additionally, patients should take care to avoid inhaling vapors associated with the product.

If any discomfort persists during use, patients are advised to discontinue use and consult a healthcare professional for further guidance.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Flobow Wart Remover (salicylic acid 17% wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is essential to evaluate the potential risks and benefits in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with liver problems, as the absence of specific guidance necessitates careful evaluation of potential risks and benefits.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate assessment of the patient’s condition is crucial. Recommended actions include:

1. Assessment: Conduct a thorough evaluation of the patient, including vital signs and level of consciousness.

2. Supportive Care: Initiate supportive measures as necessary, which may include airway management, oxygen supplementation, and intravenous fluids.

3. Decontamination: If appropriate and within a reasonable timeframe, consider gastrointestinal decontamination methods such as activated charcoal, provided the patient is alert and able to protect their airway.

4. Consultation: Engage with a poison control center or toxicology expert for guidance on specific antidotes or additional management strategies tailored to the substance involved.

It is imperative for healthcare professionals to document all findings and interventions meticulously and to monitor the patient closely for any evolving symptoms or complications.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical help or contact a Poison Control Center if the product is swallowed. It is important to inform patients that the product should not be applied to irritated or infected skin, or to areas that are reddened.

Patients with diabetes or poor blood circulation should be cautioned against using the product without prior consultation. Additionally, healthcare providers should instruct patients to avoid applying the product on birthmarks, warts with hair growth, or moles.

Patients should be informed to stop using the product and consult a doctor if discomfort persists. For those who are pregnant or breastfeeding, it is essential to recommend consulting a health professional before use to ensure safety.

Storage and Handling

The product is supplied in a tube format, with specific handling and storage requirements to ensure its integrity and efficacy. It should be stored at room temperature, away from direct light exposure. To maintain the quality of the product, it is essential to keep the tube tightly closed when not in use. Additionally, the product should be discarded after opening to prevent any potential degradation or contamination.

Additional Clinical Information

The product is administered topically, with a recommended application of a small amount to cover each wart. Patients should allow the application to dry and may repeat this process twice daily as needed, for a duration of up to 12 weeks. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Flobow Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)